Essilor/Luxottica (M.8394) [Archived]
Essilor/Luxottica (M.8394) [Archived]

The following Competition guidance note provides comprehensive and up to date legal information covering:

  • Essilor/Luxottica (M.8394) [Archived]
  • Case facts
  • Timeline
  • Commentary

CASE HUB

ARCHIVED–this archived case hub reflects the position at the date of the decision of 1 March 2018; it is no longer maintained.

See further, timeline and commentary.

Case facts

Outline European Commission merger investigation into the proposed acquisition of Luxottica by Essilor (Case M.8394). The transaction involves horizontal and vertical overlaps in markets for optical lenses and eyewear.

Latest developments The Commission unconditionally cleared the transaction after its phase II investigation on 1 March 2018.

Parties Essilor is a French-based company that produces ophthalmic lenses along with ophthalmic optical equipment. Its flagship brands are Varilux, Crizal, Transitions, Eyezen, and Xperio. Essilor also sells optical machines, optical instruments and eyewear, and it also operates optician retail businesses, mainly outside of Europe.

Luxottica is an Italian-based company producing and selling premium, luxury and sports eyewear, including under the Ray-Ban, Oakley and Persol brand, as well as more than 15 licensed brands including Armani, Chanel, Dolce & Gabbana, Prada and Versace. Luxottica also operates optician retail businesses, mainly in the US but also in Italy through Salmoiraghi & Viganò, in the UK through David Clulow and